CME Activities

Webcast Details

Return to Search

Latest Discoveries in Alzheimer’s Disease

All webcasts are free to view. You must only pay if you wish to access the post test following the webcast, in order to earn CME credit. You must be logged in to take the Post-Test.

07/02/2021 - 07/02/2024
Rawan Tarawneh, MD
Dr. Rawan Tarawneh
As a result of this educational activity, webcast participants will be able to: Understand the pathology of Alzheimer disease, including the clinical and pathological heterogeneity and the importance of
biomarkers for an accurate diagnosis; Learn about the new FDA-approved anti-amyloid agent aducanumab (approved June 2021).

Today on MedNet21, we're going to discuss Latest Discoveries in Alzheimer’s Disease.

This presentation targets general neurologists as well as family physicians and general practitioners. Given the title, the discussion spans clinical and scientific knowledge. This presentation covers the following areas:

- An overview of AD pathology
- Review of fluid (CSF and blood) biomarkers for AD
- Knowledge of the new biomarker-based definition of the disease which replaces clinical definition in
   research settings
- A review of the new FDA-approved anti-amyloid treatment aducanumab including its mechanism of     action, clinical efficacy, and potential side-effects
- Update on new approaches to biomarker and drug discovery

Type Price
Standard Price $25.00
OSU Affiliated Faculty/Staff $0.00
MedNet 21 Hospital Subscribers $0.00
Accreditation Statement

The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University Center for Continuing Medical Education (CCME) designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit is only awarded after successful completion of post-test.
ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Technical Support
Click Here for technical support documentation.
Downloadable Files
to view PDFs download Adobe Reader
LatestDiscoveriesAlzheimer'sDisease - 2
LatestDiscoveriesAlzheimer'sDisease - 4
LatestDiscoveriesAlzheimer'sDisease - 2 - color
Disclosure Information for Planning Committee Members and Speakers
Listen to Audio Only CME Podcasts
You must be logged in to take the Pre-Test
You must be logged in to take the Post-Test.
My CCME Account
CCME Username
Your username is an email address
Forgot Your Password?